The prostate is an androgen-sensitive organ that needs proper androgen/androgen receptor (AR) signals for normal development. The progression of prostate diseases, including benign prostate hyperplasia (BPH) and prostate cancer (PCa), also needs proper androgen/AR signals. Tissue recombination studies report that stromal, but not epithelial, AR plays more critical roles via the mesenchymal-epithelial interactions to influence the early process of prostate development. However, in BPH and PCa, much more attention has been focused on epithelial AR roles. However, accumulating evidence indicates that stromal AR is also irreplaceable and plays critical roles in prostate disease progression. Herein, we summarize the roles of stromal AR in the development of normal prostate, BPH, and PCa, with evidence from the recent results of in vitro cell line studies, tissue recombination experiments, and AR knockout animal models. Current evidence suggests that stromal AR may play positive roles to promote BPH and PCa progression, and targeting stromal AR selectively with AR degradation enhancer, ASC-J9, may allow development of better therapies with fewer adverse effects to battle BPH and PCa. (Am J Pathol 2015, 185: 293e301; http://dx
The prostate contains mainly the stromal cells and epithelial cells that are separated by base members and merged in extracellular matrix. Stromal cells include fibroblasts, smooth muscle cells (SMCs), and other minor inflammatory cells, nerve cells, and endothelial cells.
The prostate is developed from the endodermal urogenital sinus 1 that contains an outer layer of embryonic connective tissue urogenital sinus mesenchyme (UGM) and an inner layer of urogenital sinus epithelium (UGE). 1 The initial step of prostate development in UGM involves the differentiation of fibroblasts and SMCs, 1 and in response to the UGM androgen/ androgen receptor (AR) signals, UGE can grow into the surrounding stromal cells and develop into the prostate epithelial cells as part of the normal prostate development.
The ability of the UGM to induce epithelial development and the developed epithelial cells, in return, to direct UGM to undergo differentiation, suggesting that the reciprocal developmental interactions between UGM and UGE might be governed by androgen/AR signals, which are essential for the development of normal prostate, benign prostate hyperplasia (BPH), and prostate cancer (PCa). Prostate development factors, including its proliferation, differentiation, morphogenesis, and functional maintenance, are all influenced by androgen/AR signals. 2 Androgen/AR signals also play vital roles in the initiation and progression of BPH and PCa, 3, 4 which may require the proper interaction with various AR coregulators. 2 AR is a member of the nuclear receptor superfamily that can be activated and translocated from cytoplasm to nucleus after binding the testosterone or dihydrotestosterone. 5e7 In prostate, AR is expressed in both epithelial and stromal tissues. The transactivated AR in nucleus may then function through modulation of various downstream target genes to influence the development and maintenance of the prostate. In addition to influencing cell growth directly, epithelial AR and stromal AR can also function through epithelial-mesenchymal transition (EMT) to influence prostate development. EMT is a process by which epithelial cells lose their cell-cell adhesion and gain migratory properties to become mesenchymal-like and/or mesenchymal stem cells. These potent mesenchymal cells may then differentiate into different cell types to influence the progression of BHP 8 and PCa. 9 This review will focus on the discussion of the roles of stromal AR in the development of normal prostate and prostate diseases.
AR Roles in Normal Prostate Development
Accumulating evidence suggests that androgens through AR in embryonic stromal cells, but not in epithelial cells, direct the development of the prostate via mesenchymal-epithelial interactions. 10 Early studies suggested that during the embryonic stage, UGM may promote prostate development via inducing epithelial bud formation, eliciting prostatic bud growth, and regulating ductal branching, as well as promoting epithelial differentiation and determining the secretory protein expressions.
11e13 More important, these UGM-mediated functions may be through androgens/AR signals to influence the normal prostate development. 14 This conclusion is further strengthened from immunostaining data showing detection of AR only in the early UGM and not in the UGE. 15 The stromal androgens/AR signals may function through modulation of different growth factors, including fibroblast growth factors (FGFs 16 ), keratinocyte growth factor, 17 insulin-like growth factor (IGF 18 ), and vascular endothelial growth factor, 17 to promote adjacent epithelium growth and differentiation in a temporal and spatial manner. 19 However, so far no single growth factor was able to completely replace the stromal AR roles, suggesting stromal AR may need to modulate multiple factors to influence the mesenchymalepithelial interactions for the proper prostate development. 20 
Evidence from in Vitro Studies
In the prostate, cell proliferation and differentiation are influenced by many AR-modulated growth factors, including transforming growth factor (TGF), IGF, FGF, and epidermal growth factor. In established primary cell lines from human prostatic stroma, androgen influences the proliferation, differentiation, and regression of stromal cells by regulating the expression of TGF-b, basic FGF, AR, and SMC-specific proteins. 21 Dihydrotestosterone has a significant stimulatory effect on stromal cell growth via increasing the production and/or secretion of growth factor(s), including basic FGF-like human pituitary growth factor 22 in human prostatic fibroblasts isolated from fetal prostate. Similar phenomenon in stromal cells derived from primary culture of explanted human normal or benign prostatic tissue is also observed.
23
Androgens can induce stromal-derived keratinocyte growth factor to stimulate prostate epithelial cell growth. 23 In rat ventral stromal cells, androgen/AR signals can stimulate myodifferentiation of stromal cells, 24 and stromal AR can modulate Ca 2þ metabolism through the direct regulation of the Stim1 gene 25 or stimulate epidermal growth factor receptor signaling to influence the prostate development. 26 Knocking down AR in prostate stromal cells (PrSCs) may affect the expression of growth factors resulting in the repression of prostate growth. In primary cultured cells isolated from fibroblast specific protein 1-Cre AR knockout (FSP-ARKO) mice, the loss of AR in stromal fibroblasts decreases prostate development. 27 Co-culturing these ARKO stromal fibroblasts with the prostate epithelial BPH-1 cells can then decrease the growth of BPH-1 cells, with decreased expression of various growth factors, including IGF-1, FGF-2, FGF-7, FGF-9, FGF-10, vascular endothelial growth factor-b, and placental growth factor in the stromal fibroblasts.
27
Knocking down AR in primary cultured cells suppresses prostate growth in primary cultured cells isolated from mice with AR knocked out in the stromal SMCs (SM-ARKO). However, instead of functioning through modulation of many growth factors, AR in the SMC is more specific and modulates only IGF-1 signaling. 28 In studies with immortalized PrSCs from wild-type (WT) mice and selective double-knockout AR (dARKO) mice, PrSCs from WT mice promote prostate epithelium growth significantly compared with those from dARKO mice. 18 Stromal AR might function through the modulation of IGF-1, placental growth factor, and secreted phosphoprotein-1 to influence epithelial cell growth. 18 Together, results from various stromal cell lines studies conclude that stromal AR may play essential roles for the prostate development.
UGM-UGE Tissue Recombination Approaches in Prostate Development
Tissue recombination techniques have been used for >50 years to study the cellular biological features of both developing and adult organs. The earlier studies for the prostate recombination technique were conducted by Cunha et al, 29 who evaluated the mesenchymal induction of prostatic epithelium. By using renal capsule implementation of tissue recombinants, 30 it was demonstrated that AR in stromal, but not in epithelial, cells plays essential roles for the prostate development via influence of ductal morphogenesis, epithelial differentiation, apoptosis, and proliferation. In tissue recombinants of mesenchyme and epithelial cells from WT and AR-deficient testicular feminization (Tfm) mice, tissue recombinants composed of Tfm-UGM þ Tfm-epithelium fail to form prostate even in the presence of androgens. However, WT-UGM þ WT-epithelium tissue recombinants form prostate in response to androgens. 31 More important, Tfm-UGM þ WT-epithelium tissue ajp.amjpathol.org -The American Journal of Pathology recombinants fail to develop prostate in the presence of androgens, suggesting a critical role of mesenchymal AR, but not epithelium AR, in prostate development. This conclusion was further confirmed in the reciprocal WT-UGM þ Tfm-epithelium tissue recombinant study in which AR-deficient Tfm epithelium underwent androgen-dependent ductal morphogenesis, epithelial proliferation, and columnar cytodifferentiation, thus forming glandular epithelium resembling the prostate. 20 Together, results from tissue recombinant experiments concluded that many androgenic effects on prostatic epithelial development require the paracrine action of AR-positive mesenchyme. Even later analysis of Tfm/WT tissue recombinants also revealed that epithelial AR might also play some roles to induce some AR downstream secretory proteins. 32 Evidence from in Vivo Mouse Models ARKO mouse models with selective knockout of AR in either prostate epithelial or stromal cells 27,33 also help us better understand the specific roles of stromal AR in prostate development.
By using the Cre-loxP system to generate the floxed AR mice, and then mating with FSP1 Cre mice, Yu et al 27 successfully generated male mice with the AR gene selectively deleted in prostate stromal fibroblasts (named FSP-ARKO), and reported the ventral prostate lobes of FSP-ARKO mice to be lighter than WT littermates. Tissue histological analysis of ventral prostate lobe shows changed epithelial cells with more cuboidal and flattened shapes in prostate ducts of FSP-ARKO mice; the WT prostate epithelial cells remain columnar. These results suggested that knocking out AR in prostate stromal fibroblasts might reduce epithelial differentiation in prostate. Proliferation reduces with increased apoptosis in the FSP-ARKO ventral prostates. These results suggest that AR in prostate stromal fibroblasts plays positive roles to stimulate the prostate development.
In SM-ARKO mice, the prostates of SM-ARKO mice have no significant difference in gross appearance and branching morphogenesis compared to WT mice. However, hematoxylin and eosin staining shows defective structures in the SM-ARKO mice prostates, suggesting that knocking down AR might result in fewer epithelial in-foldings into the lumens. The morphological changes of SM-ARKO mouse prostates are due to the defective epithelium proliferation, which is mainly mediated by stromal SMC-secreted IGF-1. IGF-1 is a key AR-modulated growth factor in prostate for proliferation and morphogenesis.
34e36 Knocking down AR in the SM-ARKO mice significantly suppresses IGF-1 expression in anterior and ventral prostates.
In double-stromal AR knockout mice (with selectively deleted AR in both stromal fibroblasts and SMCs, named dARKO), the size of the anterior prostate lobes is significantly reduced. Decreased proliferation and increased apoptosis in the epithelial cells of dARKO mouse anterior prostates are also observed. 18 Dissection of the mechanism in the PrSCs, isolated from dARKO mice, confirms that IGF-1 is the key mediator of stromal AR function for normal prostate growth. 18 Together, results from various ARKO mice conclude that AR in prostate stromal fibroblasts or SMCs plays positive roles to stimulate normal prostate development (Figure 1 ).
AR Roles in BPH
Human prostate consists of three distinct histological zones: central, peripheral, and transition. Nearly all clinically significant BPH develops in the transition zone of the prostate. Macroscopic growth of the transition zone can cause narrowing of the urethra as it passes through the prostate, leading to a bladder outlet obstruction, which may affect the flow of urine. BPH is the most common benign neoplasm in American men and affects almost three-quarters of men during the seventh decade of life. 37 BPH-induced lower urinary tract symptoms, including bladder outlet obstruction, contribute to a spectrum of urinary voiding problems that can significantly affect quality of life. The etiology of BPH remains unclear. An early study indicated that BPH contains mainly stromal cells (88.4%), with only 9.0% epithelial cells, 38 suggesting the stromal cells may play more important roles in the development of BPH, even though both the stromal and epithelial components are involved in the development of BPH. McNeal 39 hypothesized that the reversion of the stroma to an embryonic phenotype and the formation of hyperplastic stromal nodules are the earlier events in BPH, and the de novo formation of epithelial glands in BPH is a later event, which is induced by paracrine factors from the stromal nodules, emphasizing that stroma may play an important role in influencing BPH development.
The stromal androgens/AR signals may influence the initiation and progression of BPH via alteration of the various growth factors in the paracrine and/or autocrine manner. 40, 41 For example, factors involved in alteration of cell proliferation/differentiation 42 or stem cell population, 43 as well as factors involved in the EMT 8 or inflammation/ immune tolerance, 44, 45 have been suggested to be directly or indirectly linked to the AR. Therefore, targeting androgens/ AR signals continue to play key roles in battling the progression of BPH.
38,46
Evidence from in Vitro Studies
There are three reported mechanisms by which prostate AR promotes the development of BPH. The first mechanism is to influence the proliferation of prostate cells directly from stromal AR. AR tissue compartment assays indicate that BPH tissue has much higher AR expression compared to adjacent normal glandular tissue. 47, 48 In epithelial cells and stromal cells isolated from BPH tissue, androgen can induce the expression of FGF-10 in stromal cells, but not epithelial cells, to stimulate human prostatic epithelial proliferation. 49 In primary cultured and PrSC stromal cell lines, stromal AR might play positive roles to promote epithelial cell growth, and targeting AR signals in stromal cells can suppress the growth of BPH cells, suggesting that AR in stromal cells may play positive roles to promote BPH development. 27, 28, 50 The second mechanism involves targeting epithelial AR to influence BPH development via modulation of EMT. 51 EMT, which is characterized by decrease of epithelial markers, including E-cadherin, and increase of mesenchymal (stromal) factors, including N-cadherin, vimentin, and Snail, 52 is a continual progression of epithelial cells to acquire the motile characteristics of mesenchymal cells. 51 EMT might influence cells in regions of the ductal epithelium, resulting in loss of their polarization, with little E-cadherin expression.
8 Snail2/Slug is an important transcription factor for TGF-b1einduced EMT in the development of BPH. 53 AR in BPH-1 and mPrE cells significantly increases macrophage THP-1 and RAW264.7 cell migration in co-cultures. 54 These recruited macrophages might then function through enhanced EMT to promote BPH development and progression, suggesting that AR in prostate epithelial cells might play a positive role in promoting macrophage-mediated EMT to enhance BPH development. 54 The third mechanism involves stromal AR functions through the recruitment of macrophages to enhance the stromal cell proliferation. 55 Early studies demonstrated that inflammation is a potential causative factor for BPH development and progression. 44, 45, 56 In a co-culture system, mouse PrSCs have the capacity to recruit more infiltrating macrophage RAW264.7 cells, which can then enhance stromal cell proliferation. 55 Mouse PrSCs may secrete chemokine ligand 3 as an AR downstream target to influence macrophage recruitment, and targeting ARechemokine ligand 3 signals may suppress BPH development via interruption of macrophage infiltration. 55 Together, AR may function through either stromal AR to directly promote BPH development or epithelial cells to recruit macrophages to enhance EMT to influence BPH development. In addition, AR may work via recruitment of macrophages directly to stromal cells to promote BPH development.
Evidence from Tissue Recombination Approaches
Because several key factors from BPH microenvironment and interactions between epithelium and stroma are not easy to study via the in vitro cell line system, the tissue recombination approaches were developed to better evaluate the AR roles in the BPH microenvironment for their impact on epithelial-stromal interactions.
Use of tissue recombination approaches to compare the stromal cells from the peripheral zone of BPH versus normal prostate to induce the growth of epithelial BPH-1 cells revealed that BPH-1 cells mixed with stromal cells isolated from BPH, and not from normal prostate, can generate the grafts with proper development. 57 Histological examination of these grafts revealed densely packed, well-organized, tubular epithelium with minimal stroma, sharply demarcated from the surrounding renal tissue. Stromal AR, and not epithelium AR, is critical in BPH development. 58 
Evidence from ARKO Mouse Models
By using prostate stromal double-ARKO (AR was knocked out in both fibroblasts and SMCs) mice to mate with the prolactin transgenic mice, Lai et al 59 generated the first BPH mouse model (dARKO/prolactin transgenic) that selectively deleted AR in stromal fibroblasts and SMCs. They showed that loss of AR in stromal fibroblasts and SMCs can result in the development of the smaller prostates with a lower proliferative index, better urination function, and normal bladder volume. 59 Prolactin-induced hyperplastic prostate growth involves the epithelial-stromal interaction. Epithelial autonomous prolactin/prolactin receptoregranulocyte macrophage colony stimulating factor signaling in a paracrine manner to facilitate stromal cell growth, and stromal AR, can modulate granulocyte colony stimulating factoreSTAT3 signaling to control epithelium cell growth. These findings were confirmed using single AR knockout from fibroblasts or SMC mouse models. Previous findings that the stromal AR might play positive roles to promote BPH development were further validated in specific SMC ARKO mice 60 ; knocking out SMC AR in adult male mouse prostate results in dramatically decreased anterior prostate lobe, dorsolateral prostate lobe, and ventral prostate lobe weights.
Together, results from in vivo mice studies confirm the data from in vitro cell lines and tissue recombination studies showing that the AR in stromal smooth muscle and fibroblasts is the key player in promoting BPH development via modulating the epithelial-stromal interaction (Figure 2) .
Clinically, the most inconvenient symptoms induced by BPH are lower urinary tract symptoms that may be treated by either a-blockers or 5a-reductase inhibitors to suppress testosterone conversion to more potent dihydrotestosterone. However, not all of the patients are sensitive to these therapies and some still need surgery. Further clinical trials to prove the above conclusion showing AR in stromal and ajp.amjpathol.org -The American Journal of Pathology epithelial cells may play key roles in promoting development of BPH, which may help us develop new and better therapies via targeting AR in stromal and epithelial cells.
54,61

Stromal AR Roles in PCa
PCa is the leading cancer in men in the United States, 62 and it may affect one-sixth of men. 63 PCa was proved to originate from epithelial cells. 62 Since the discovery of Huggins and Hodges in 1941, 64 the vital roles of androgens/AR signals have been realized well, and androgen deprivation therapy to prevent or reduce androgen binding to AR, which may suppress tumor progression in most of the cases in the first 1 to 2 years, 65 has been the standard therapy to treat the advanced PCa.
Prostate tumorigenesis has been regarded as a largely cell-autonomous process that may involve genetically transformed epithelial cells. Interestingly, although the epithelial AR roles in the influence of PCa development have been well studied, the stromal AR roles in the development of PCa remain relatively unclear. PCa stroma is composed of fibroblasts, SMCs, extracellular matrix, and other infiltrating cells in the prostate tumor microenvironment. Normal prostate stromal compartment has the inherent plasticity to respond rapidly to emerging situations, including disrupted homeostasis with tumor development. During emerging situations, stromal cells may alter the phenotypic and genotypic changes to become the so-called reactive stroma, 69 which mainly includes the changes of SMA and activation of carcinoma-associated fibroblasts (CAFs) or myofibroblasts.
SMCs, one of the main components of stromal cells, express AR and respond to androgens to maintain the highly differentiated secretory epithelium via homeostatic stromalepithelial interactions in PCa. 70 The fibroblasts, another main component of stromal cells, can be influenced/activated by the surrounding cancer epithelial cells, 71 and in return, these fibroblasts can then potentially promote the growth and invasion of PCa. 72 Interestingly, the phenotypes of these activated fibroblasts (named CAFs) are more closely related to the myofibroblasts, and may function through their AR to promote the PCa cell growth and invasion. 73 
Evidence from in Vitro Studies
To analyze the stromal AR roles in PCa development, the immortalized CAFs were co-cultured with the PCa epithelial PC-3 cells; the capability of CAFs to promote PC-3 cell proliferation and invasion is interrupted by knocking down AR, which involves the modulation of the expression of IGF-1, FGF7, FGF10, stromal derived factor 1, hepatocyte growth factor, and TGF-b2. 73 These data suggested that the AR in CAFs might be able to promote PCa epithelial growth and invasion via regulating the expression of the growth factors. 73 Via transfecting a functional AR-cDNA into the immortalized human PrSC WPMY-1 (named WPMY-AR), WPMY-AR cells were reported to be more responsive to dihydrotestosterone stimulation, which results in better modulation of AR target genes, transcribing TGF-b, Wnt, hedgehog, and mitogenactivated protein kinase. 74 These genes are also involved in the stromal-epithelial cross talk. The consequences of altering these stromal AR-mediated signals might promote the epithelial (LNCaP) cell growth.
Interestingly, opposite results for the stromal AR roles in PCa progression were also reported. AR levels decrease in PCa tumor-surrounding stromal cells, especially in androgenindependent cancers. 75 By using two different telomeraseimmortalized human stromal cell lines, either AR positive or AR negative, it was reported that stromal cells lacking AR might promote the PCa epithelial cell proliferation and invasion. 75 Furthermore, adjacent stromal AR expression negatively correlates with progression of PCa: the lower expression of AR in adjacent stroma is linked to the early relapse in PCa. 76 
Evidence from the Tissue Recombination Approaches
The concept that stromal cells may play a role in carcinogenesis was also proved by the tissue recombination studies. Evidence from in vitro cell line studies, recombination experiments, and AR knockout animal models demonstrates that stromal AR can promote PCa growth, metastasis, and tumorigenesis. FGF, fibroblast growth factor; HGF, hepatocyte growth factor; IGF, insulin-like growth factor; MIP, macrophage inflammatory protein; SDF, stromal derived factor; TGF, transforming growth factor. the invasive carcinomas in the presence of testosterone propionate (T) and 17-b-estradiol (E2). In contrast, the epithelial cells might lead to cell apoptosis when the recombinants are not treated with T þ E2 or host mice are castrated. These results suggest that the nontumorigenic BPH-1 cells can undergo hormonal carcinogenesis in response to T þ E2 stimulation. However, although BPH-1 cells can survive and grow in the absence of UGM, they could not form the tumors or organized structures, suggesting that the PrSCs play an important role in mediating hormonal carcinogenesis. 77 Because BPH-1 cells express little AR and ER, whereas rat UGMs express both AR and ERa, it is likely that T þ E2 may function through the stromal AR and ERa to promote prostate tumorigenesis. 78 Interestingly, T þ E2 treatment promotes the metastases of murine UGM1 and BPH-1 recombinants, leading to carcinoma. 79 Tissue recombinants with AR-negative stromal cells derived from mouse UGM and AR-negative human benign prostatic epithelial cells fail to develop into tumors. In contrast, tissue recombinants composed of WT stromal cells and WT epithelial cells develop into much larger and invasive tumors. 79 In tissue recombination of human prostate WPMY1 stromal cells with human PCa epithelial PC-3 cells, the stromal AR might function as a stimulator in PCa cell growth and metastases in the orthotopic xenografted prostate tumors. These data suggest that stromal AR might play important roles in the PCa initiation and progression.
Evidence from in Vivo Mouse Models
Tissue-specific AR knockout mouse models 80 were also applied to prove the essential roles of stromal-epithelial interaction for the PCa development. Niu et al 4 generated inducible ARKO-TRAMP and prostate epithelial-specific ARKO TRAMP mouse models, in which the AR was knocked out in both, or separately, in prostate epithelial and stromal cells. The results showed that in inducible ARKO-TRAMP mice, knocking out AR in both epithelial and stromal cells at earlier stages results in smaller primary prostate tumors with lower proliferation rates. And in prostate epithelial-specific ARKO-TRAMP mice, knockout of prostate epithelium AR results in larger primary prostate tumors with higher proliferation rates. These results indicate that the prostate stromal AR might play more important roles than the epithelial AR to promote primary tumor proliferation at the early stages of tumor development.
In the established animal model with AR deletion in stromal fibromuscular cells (dARKO; AR knockout in fibroblasts and SMCs), loss of stromal fibromuscular AR suppresses prostate tumorigenesis development. 80 Stromal AR plays roles in the alterations of the tumor microenvironments, such as extracellular matrix remodeling, angiogenesis, and immune cell infiltration. By comparing the stromal cells isolated from WT mice and stromal cells from ARKO mice, they further proved that stromal AR was able to regulate proinflammatory cytokine/chemokine expression [eg, macrophage inflammatory protein (Mip)-1a, Mip-1b, Mip-2, and Il-10] to affect immune cell recruitment and modulate inflammatory responses in mouse prostate. For example, AR may cooperate with NF-kB to activate MIP-1b promoter (Ccl4) after Il-1b stimulation, instead of directly binding to Mip-1b promoter 80 ( Figure 3 ).
Conclusions and Perspective
Some studies demonstrated that epithelial AR in PCa functions can be opposite and complicated. 81, 82 These opposite epithelial AR roles might lead to different functions, which explains why androgen deprivation therapy cannot completely suppress PCa. 81 In contrast, stromal AR seems to play more consistent roles. At the embryonic phase, stromal AR may promote prostate development via inducing epithelial bud formation, eliciting prostatic bud growth, and regulating ductal branching, as well as promoting epithelial differentiation and determining the secretory protein expressions.
11e13 Stromal AR also can promote the initiation and progression of BPH through many mechanisms. 49, 55 Similar to BPH, the positive roles of stromal AR in PCa are well demonstrated. 4, 83 The conclusion that stromal AR plays key roles in promoting the development of BPH and PCa suggests that targeting stromal AR can provide a potential therapeutic approach to suppress the progression of BPH and PCa. ASC-J9, a newly developed AR degradation enhancer, degrades AR in selective cells via interruption of interaction between AR and selective AR coregulator ARA55 in stromal cells. 84 Early studies suggest that AR coregulator ARA55 can bind to WT AR and mutant AR (named mART877S; point mutation threonine to serine at codon 877) in a ligand-dependent manner to enhance their transcriptional activities 85 and influence the progression of PCa. 86 ASC-J9 has been well proved to suppress the progression of BPH via degradation of WT AR and mutant AR in the prostate. Multiple mechanisms are involved, including the suppression of macrophage-induced PrSCs proliferation, 55 EMT-induced BPH, 54 prolactin-driven BPH, 59 and alteration of branching morphogenesis. 18 Similarly, the effect of targeting stromal AR-ARA55 interaction to suppress PCa via ASC-J9 might involve the interruption of TGF-beSmad3ematrix metalloproteinase 9 signals, 87 infiltrating macrophage-chemokine ligand 2-STAT3 signals. 88 In conclusion, results from above studies suggest that targeting stromal AR may help us develop some new therapeutic approaches to better suppress prostate diseases. ajp.amjpathol.org -The American Journal of Pathology
